Mark James Docherty
Directeur Général chez DHP Private Equity GmbH
Profil
Mr. Mark J.
Docherty is a Managing Director at DHP Private Equity GmbH and Finance Director at FKD Therapies Oy.
He is on the Board of Directors at ReNeuron Group Plc, Onyvax Ltd., CBT Development Ltd., PanTherix Ltd., and Finvector Vision Therapies Ltd.
Mr. Docherty was previously employed as Non-Executive Director by Plethora Solutions Holdings Plc, Investment Director & Founder by Excalibur Fund Managers Ltd., a Manager-Corporate Finance Group by Arthur Andersen, and Non-Executive Director by BioWisdom Ltd.
He received his undergraduate degree from The University of Sheffield.
Postes actifs de Mark James Docherty
| Sociétés | Poste | Début |
|---|---|---|
| CBT Development Ltd. | Directeur/Membre du Conseil | 18/11/2010 |
FKD Therapies Oy
 FKD Therapies Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, FKD Therapies Oy is a Finnish pharmaceutical company that manufactures and markets products for cancer treatment. The company is based in Kuopio, Finland. FKD Therapies was acquired by Ferring International Center SA on June 01, 2014. | Directeur Financier/CFO | - |
Finvector Vision Therapies Ltd.
 Finvector Vision Therapies Ltd. Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, Finvector Vision Therapies Ltd. is a British pharmaceutical company that manufactures and markets products for cancer treatment. The company is based in Chinnor, UK. Finvector Vision Therapies was acquired by Ferring International Center SA on June 01, 2014. | Directeur/Membre du Conseil | - |
| DHP Private Equity GmbH | Directeur Général | 03/12/2013 |
Trizell Ltd.
 Trizell Ltd. BiotechnologyHealth Technology Trizell Ltd. engages in research and experimental development on biotechnology. The company was founded on April 14, 1997 and is headquartered in Chinnor, the United Kingdom. | Directeur/Membre du Conseil | 15/03/2013 |
Anciens postes connus de Mark James Docherty
| Sociétés | Poste | Fin |
|---|---|---|
| RENEURON GROUP PLC | Directeur/Membre du Conseil | 30/09/2015 |
BioWisdom Ltd.
 BioWisdom Ltd. Packaged SoftwareTechnology Services After nearly ten years in the Healthcare Intelligence Business, BioWisdom knows that it's not just about the data, it's about the metadata. Metadata brings data to life, it provides context, it transforms, translates and makes relevant those noisy, digital tomes. Intelligent Metadata helps to maximize the value of its customers content whether it's brand new or ancient history. That legacy of expertise, observation, labor and investment. | Directeur/Membre du Conseil | 30/10/2013 |
Excalibur Fund Managers Ltd.
 Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur Fund Managers Ltd (Excalibur) is a venture capital firm founded in 1996 by Christopher Evans. The firm is headquartered in London, United Kingdom. | Fondateur | 30/09/2011 |
| PLETHORA SOLUTIONS HOLDINGS PLC | Directeur/Membre du Conseil | 25/05/2009 |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Mark James Docherty
| The University of Sheffield | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RENEURON GROUP PLC | Health Technology |
| Entreprise privées | 12 |
|---|---|
Plethora Solutions Holdings Plc
 Plethora Solutions Holdings Plc Pharmaceuticals: MajorHealth Technology Plethora Solutions Holdings Plc operates as a pharmaceutical company. It engages in the development and marketing of products for the treatment and management of urological disorders. The firm operates through the Plethora Development and The Urology Co. segments. The Plethora Development segment develops new pharmaceutical products. The Urology Co. segment sells and markets pharmaceutical and healthcare products. The company was founded by Michael Grant Wyllie and Neil Brent Stafford in December 2003 and is headquartered in Chalgrove, the United Kingdom. | Health Technology |
Excalibur Fund Managers Ltd.
Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur Fund Managers Ltd (Excalibur) is a venture capital firm founded in 1996 by Christopher Evans. The firm is headquartered in London, United Kingdom. | Finance |
PanTherix Ltd.
 PanTherix Ltd. Pharmaceuticals: GenericHealth Technology PanTherix Ltd. is a privately held anti-infectives company using structure-based drug design to discover and develop new antibiotics acting on novel targets. The company integrates structural and functional information obtained by protein crystallography and enzymology to accelerate the gene to drug process. The company was founded in 1997 and is headquartered in Glasgow, the United Kingdom. | Health Technology |
Onyvax Ltd.
 Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Onyvax Ltd. developed cancer remedy therapies. The company was founded in 1995 and was headquartered in Bradford, the United Kingdom. | Commercial Services |
EpiCept Corp.
 EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Health Technology |
BioWisdom Ltd.
BioWisdom Ltd. Packaged SoftwareTechnology Services After nearly ten years in the Healthcare Intelligence Business, BioWisdom knows that it's not just about the data, it's about the metadata. Metadata brings data to life, it provides context, it transforms, translates and makes relevant those noisy, digital tomes. Intelligent Metadata helps to maximize the value of its customers content whether it's brand new or ancient history. That legacy of expertise, observation, labor and investment. | Technology Services |
Arthur Andersen (UK)
 Arthur Andersen (UK) Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Arthur Andersen (UK) is a British company that provides accounting services. The company is based in Reading, UK. | Commercial Services |
| CBT Development Ltd. | |
FKD Therapies Oy
FKD Therapies Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, FKD Therapies Oy is a Finnish pharmaceutical company that manufactures and markets products for cancer treatment. The company is based in Kuopio, Finland. FKD Therapies was acquired by Ferring International Center SA on June 01, 2014. | Health Technology |
Finvector Vision Therapies Ltd.
Finvector Vision Therapies Ltd. Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, Finvector Vision Therapies Ltd. is a British pharmaceutical company that manufactures and markets products for cancer treatment. The company is based in Chinnor, UK. Finvector Vision Therapies was acquired by Ferring International Center SA on June 01, 2014. | Health Technology |
| DHP Private Equity GmbH | Finance |
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Trizell Ltd. engages in research and experimental development on biotechnology. The company was founded on April 14, 1997 and is headquartered in Chinnor, the United Kingdom. | Health Technology |